Antibiotic-associated diarrhea
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Propionic acidemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
17
|
124
|
0.100 |
None |
|
0 |
3
|
|
|
Vaccinia virus infection
|
disease |
|
Disease or Syndrome
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Pancreatic Endocrine Carcinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Acute myocarditis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Gastrointestinal tract vascular insufficiency
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
68
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Vascular insufficiency of intestine
|
disease |
Digestive System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
68
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Tumor-Associated Vasculature
|
disease |
|
Acquired Abnormality
|
84
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Angiogenic Switch
|
disease |
|
Neoplastic Process
|
96
|
3
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Melanoma, B16
|
disease |
Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
157
|
1
|
0.010 |
None |
< 0.001 |
1 |
|
2020 |
2020 |
Ascites
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
198
|
7
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Acidosis, Lactic
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
209
|
21
|
0.100 |
None |
|
0 |
3
|
|
|
Chronic heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
223
|
11
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
PATENT DUCTUS ARTERIOSUS 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
229
|
12
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Pancytopenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
253
|
15
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
insulinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
258
|
8
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2020 |
Papilloma
|
disease |
Neoplasms
|
Neoplastic Process
|
273
|
27
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Mitochondrial Diseases
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
284
|
84
|
0.200 |
None |
|
0 |
|
|
|
Tumor Immunity
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
337
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Refractory anemias
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
340
|
11
|
0.020 |
None |
1.000 |
2 |
|
1994 |
1996 |
Tumor necrosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
350
|
1
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2018 |
Ureteral obstruction
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
359
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Caffeine related disorders
|
group |
|
Mental or Behavioral Dysfunction
|
360
|
56
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Stage 0 Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2019 |
Stage IIA Gallbladder Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
367
|
56
|
0.030 |
None |
1.000 |
3 |
|
2014 |
2019 |